reptides › briefs › 14 Peptide Pathways for Alcohol Use Disorder

14 Peptide Pathways for Alcohol Use Disorder

The VA just put semaglutide into a 622-person Phase 3 trial. I think GLP-1s may only be the beginning.

the short answer

  • 27.9 million Americans had alcohol use disorder in 2024.
  • Only three medications are FDA-approved specifically for AUD.
  • Now the VA is putting semaglutide into a 622-person Phase 3 trial.

member brief

member brief. the full analysis is part of premium membership.

reptides grades the research record and cites the literature behind every call. research reference only; not medical advice.

reptides.